The Select trial also found Wegovy protected against heart disease even before people had lost any weight, possibly by reducing inflammation
If you notice symptoms after starting treatment, talk to your doctor to see if your medication could be the cause
Tropical Smoothie with Coconut + Protein Powder Blend frozen mango, pineapple, coconut milk, and a scoop of plant-based protein powder
In September 2022, Eli Lilly published the results of its preclinical studies on LY3437943 in the journal Cell Metabolism, in an article titled "LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept." In vitro and in vivo validation of the triple agonist effect of LY3437943: Eli Lilly's research results show that LY3437943 demonstrates superior weight loss effects compared to GLP-1 receptor (GLP-1R) selective agonists (GLP-1 RA), GLP-1R and GCGR dual agonists (Cotadutide or 05677), and GLP-1R and GIPR dual agonists
Measure your waist
Liu B, Liu Y, Li S, Chen P, Zhang J, Feng L
